Compugen CGEN
NASDAQ CGEN
$2.32 -0.02 (-1.07%)
As of: Oct 2, 2026 · 3:42 PM EDT

Compugen (CGEN) Liabilities from Discontinued Operations (2009)

Updated

Compugen (CGEN) recorded Liabilities from Discontinued Operations of $12,000 in Q2 2009, unchanged from the prior quarter.

Analysis

Compugen (CGEN) Liabilities from Discontinued Operations (2009) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Compugen 225.04 Mn -148.05 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2009 12,000.00
Mar 31, 2009 12,000.00
API Access

Compugen Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=CGEN&period=max&api_key=YOUR_API_KEY